Abstract:Xiaomei Jiang, 1, &ast Xiaohong Jiang, 2, &ast Dongjie Wu, 1 Wanzhu Xie, 3 Xiong Liu, 1 Jintao Zheng 4 1 Department of Dermatology, Liuzhou Traditional Chinese Medicine Hospital, Liuzhou, 545001, People's Republic of China; 2 Department of Pharmacy, Shantou University Medical College, Shantou, 515041, People's Republic of China; 3 Department of Rehabilitation, Liuzhou Worker's Hospital, Liuzhou, 545001, People's Republic of China; 4 Department of Biotechnology and Food Engineering, Guangdong Technology Israel Institute of Technology, Shantou, 515063, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jintao Zheng, Department of Biotechnology and Food Engineering, Guangdong Technology Israel Institute of Technology, Shantou, 515063, People's Republic of China, Tel +86 156 2584 9047, Email Background: Radiotherapy is a widely used clinical tool for tumor treatment but can cause systemic toxicity if excessive radiation is administered. Although numerous nanoparticles have been developed as radiosensitizers to reduce the required dose of X-ray irradiation, they often have limitations, such as passive reliance on radiation-induced apoptosis in tumors, and little consider the unique tumor microenvironment that contributes radiotherapy resistance. Methods: In this study, we developed and characterized a novel self-assembled nanoparticle containing dysprosium ion and manganese ion (Dy/Mn-P). We systematically investigated the potential of Dy/Mn-P nanoparticles (NPs) as a reactive oxygen species (ROS) amplifier and radiosensitizer to enhance radiation therapy and modulate the tumor microenvironment at the cellular level. Additionally, we evaluated the effect of Dy/Mn-P on the stimulator of interferon genes (STING), an innate immune signaling pathway. Results: Physicochemical analysis demonstrated the prepared Dy/Mn-P NPs exhibited excellent dispersibility and stability, and degraded rapidly at lower pH values. Furthermore, Dy/Mn-P was internalized by cells and exhibited selective toxicity towards tumor cells compared to normal cells. Our findings also revealed that Dy/Mn-P NPs improved the tumor microenvironment and significantly increased ROS generation under ionizing radiation, resulting in a ~70% increase in ROS levels compared to radiation therapy alone. This enhanced ROS generation inhibited ~92% of cell clone formation and greatly contributed to cytoplasmic DNA exposure. Subsequently, the activation of the STING pathway was observed, leading to the secretion of pro-inflammatory immune factors and maturation of dendritic cells (DCs). Conclusion: Our study demonstrates that Dy/Mn-P NPs can potentiate tumor radiotherapy by improving the tumor microenvironment and increasing endogenous ROS levels within the tumor. Furthermore, Dy/Mn-P can amplify the activation of the STING pathway during radiotherapy, thereby triggering an anti-tumor immune response. This novel approach has the potential to expand the application of radiotherapy in tumor treatment. Keywords: radiotherapy, Dy/Mn-P NPs, ROS, tumor microenvironment, STING pathway Radiotherapy (RT) is a widely used method for treating cancer in contemporary clinical practice. Regrettably, despite its unparalleled curative efficacy, the therapeutic potential of this method is hindered by unfavorable adverse effects, most notably the health hazards associated with excessive radiation doses. 1,2 Recently, the use of NPs based on metal atoms with high atomic numbers in combination with radiation therapy to enhance the effect of radiation by accumulating or releasing more in the tumor site compared to healthy tissues can effectively increase the efficiency of radiotherapy and reduce side effects. 3–5 For instance, hafnium (Hf), gold (Au), and lanthanide elements have been developed as novel radio-sensitizing nanoparticles to effectively capture more local radiation dose inside the tumor since they possess a high atomic number, thus reducing the side effects of radiation therapy. 6–12 During the RT, these radiosensitizers can interact with X-ray via several physical processes, releasing electrons and generating ROS, leading to irreparable DNA lesions and inducing tumor cell apoptosis. 13–16 However, the unique tumor microenvironment (TME) poses challenges to the effectiveness of radiation therapy. For instance, the high levels of glutathione (GSH) and hydrogen peroxide (H 2 O 2 ) within the tumor create an environment that hampers the efficacy of radiotherapy and promotes resistance to treatment. 17–20 Additionally, a lack of tumor sensiti -Abstract Truncated-

Naturally-Derived PHA-L Protein Nanoparticle As a Radioprotector Through Activation of Toll-Like Receptor 5.

Mitochondria-Targeted Nitronyl Nitroxide Radical Nanoparticles for Protection against Radiation-Induced Damage with Antioxidant Effects

Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

Dopamine-derived Nanoparticles for the Protection of Irradiation-Induced Intestinal Injury by Maintaining Intestinal Homeostasis.

TLR4 Agonist MPLA Ameliorates Heavy-Ion Radiation Damage Via Regulating DNA Damage Repair and Apoptosis.

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Metabolizable Lanthanum-Coordination Nanoparticles As Efficient Radiosensitizers for Solid Tumor Therapy

Progresses in radiation protective agents targeting Toll-like receptor pathway

Combination of natural polyphenols with a precursor of NAD+ and a TLR2/6 ligand lipopeptide protects mice against lethal γ radiation

Reactive Oxygen Species-Responsive Nanodrug of Natural Crocin-I with Prolonged Circulation for Effective Radioprotection

Anti irradiation nanoparticles shelter immune organ from radio-damage via preventing the IKK/IκB/NF-κB activation

A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection

N-formylmethionine-leucyl-phenylalanine protects against irradiation-induced damage to hematopoiesis and intestines

Abstract 811: Development of a NOX-ROS nanoinhibitor for enhancing response to radiotherapy in lung cancer cells while mitigation radiation-induced inflammation and injury in the normal lung tissue

High-throughput Preparation of Radioprotective Polymers Via Hantzsch’s Reaction for in Vivo X-ray Damage Determination

Radioprotector WR-2721 and Mitigating Peptidoglycan Synergistically Promote Mouse Survival Through the Amelioration of Intestinal and Bone Marrow Damage

Amelioration Of Radiation-Induced Skin Injury By Hiv-Tat-Mediated Protein Transduction Of Rp-I From Rana Pleurade

Design, Synthesis, and Biological Evaluation of a Novel Aminothiol Compound As Potential Radioprotector

Biomaterials-mediated radiation-induced diseases treatment and radiation protection

Administration of Recombinant Human Thrombopoietin Soon after Irradiation Promotes Survival and Stimulates Hematopoietic Recovery in a Nonhuman Primate Model of Radiation-Induced Severe Acute Radiation Syndrome

A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy